SK Bioscience Co., Ltd.
Clinical trials sponsored by SK Bioscience Co., Ltd., explained in plain language.
SK Bioscience Co., Ltd.
302440
KRX
South Korean vaccine and biopharmaceutical company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New vaccine aims to shield against multiple coronavirus types Results expected Dec 2026 (estimated)
- Could a new vaccine beat chickenpox? large trial underway Results expected Feb 2027 (estimated)